Literature DB >> 770181

Recovery from aplastic anemia following attempted marrow transplantation.

E D Thomas, R Storb, E R Giblett, B Longpre, P L Weiden, A Fefer, R Witherspoon, R A Clift, C D Buckner.   

Abstract

A 23-year-old man with severe idiopathic aplastic anemia was prepared for marrow transplantation by the administration of cyclophosphamide (CY) 50 mg/kg on each of 4 days. He then received an intravenous infusion of 9.5 x 10(9) marrow cells from an HL-A matched and mixed leukocyte culture non-reactive sister. The graft was successfully established as shown by cytogenetic studies but was rejected after approximately 4 weeks. In preparation for a second transplant he was given procarbazine 12.5 mg/kg and goat antihuman thymocyte globulin (ATG) 7 mg/kg administered on alternate days for a total of 4 doses of each agent. At the end of this therapy his white blood cell count was noted to be going up and the second transplant was not carried out. Complete hematologic recovery of host type marrow ensued and persists now 20 months later. The various pathophysiologic mechanisms that may be involved are discussed.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 770181

Source DB:  PubMed          Journal:  Exp Hematol        ISSN: 0301-472X            Impact factor:   3.084


  14 in total

Review 1.  Clinical management of aplastic anemia.

Authors:  Amy E Dezern; Robert A Brodsky
Journal:  Expert Rev Hematol       Date:  2011-04       Impact factor: 2.929

Review 2.  High-dose cyclophosphamide for autoimmunity and alloimmunity.

Authors:  Robert A Brodsky
Journal:  Immunol Res       Date:  2010-07       Impact factor: 2.829

3.  Complete remission of severe aplastic anaemia following treatment with anti-thymocyte globulin.

Authors:  M Griffin; L Coffey; S R McCann
Journal:  Ir J Med Sci       Date:  1983-08       Impact factor: 1.568

4.  Proceedings of the Annual Meeting of the European Foundation for Bone Marrow Transplantation, Sils Maria (Engadine), Switzerland, April 13-16, 1980.

Authors: 
Journal:  Blut       Date:  1980-09

5.  Inhibitory effects of peripheral blood cells on in vitro colony formation by autologous bone marrow in aplastic anaemia: relation with response to immunosuppressive therapy.

Authors:  A Blasetti; A Faille; N Balitrand; E Gluckman; A Devergie; C Dresch
Journal:  J Clin Pathol       Date:  1982-12       Impact factor: 3.411

6.  Aplastic anemia: presence in human bone marrow of cells that suppress myelopoiesis.

Authors:  W A Kagan; J A Ascensão; R N Pahwa; J A Hansen; G Goldstein; E B Valera; G S Incefy; M A Moore; R A Good
Journal:  Proc Natl Acad Sci U S A       Date:  1976-08       Impact factor: 11.205

7.  Neutropenia in three patients with rheumatic disorders. Suppression of granulopoiesis by control-sensitive thymus-dependent lymphocytes.

Authors:  G C Bagby; J D Gabourel
Journal:  J Clin Invest       Date:  1979-07       Impact factor: 14.808

8.  Effect of T-lymphocytes on normal haemopoiesis: studies in congenitally athymic nude mice.

Authors:  G Harris; S N Wickramasinghe
Journal:  Blut       Date:  1979-09

Review 9.  Intensive immunosuppression with high dose cyclophosphamide but without stem cell rescue for severe autoimmunity: advantages and disadvantages.

Authors:  Robert A Brodsky; Richard J Jones
Journal:  Autoimmunity       Date:  2008-12       Impact factor: 2.815

10.  Treatment of aplastic anemia with a monoclonal antibody directed against the interleukin-2 receptor.

Authors:  W Schwinger; C Urban; H Lackner; C Mache
Journal:  Ann Hematol       Date:  1993-04       Impact factor: 3.673

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.